Combo therapy, nanoparticle delivery system show promise for pancreatic cancer

  • 4 years ago
Combo therapy, nanoparticle delivery system show promise for pancreatic cancer
A new multi-drug combination therapy for pancreatic cancer is inching toward clinical trials in humans. The drug compound, called SapC-DOPS, combines chemotherapy with targeted therapy and can kill cancer cells.